1184 A platform for tuning therapeutic efficacy of T-Cell-engaging bispecific antibodies

• Jane Seagal,
• Arvin Akoopie,
• Alireza Ataei,
• Dana Duey,
• Olena Gorbenko,
• Ranveer Jayani,
• Fiana Levitin,
• Oscar Martinez,
• Shaden Omar,
• Ritsuko Sawada,
• Jonah Rainey

Affiliations

Jane Seagal

1AlivaMab Discovery Services, San Diego, CA, USA

Arvin Akoopie

1AlivaMab Discovery Services, San Diego, CA, USA

Alireza Ataei

1AlivaMab Discovery Services, San Diego, CA, USA

Dana Duey

1AlivaMab Discovery Services, San Diego, CA, USA

Olena Gorbenko

1AlivaMab Discovery Services, San Diego, CA, USA

Ranveer Jayani

1AlivaMab Discovery Services, San Diego, CA, USA

Fiana Levitin

1AlivaMab Discovery Services, San Diego, CA, USA

Oscar Martinez

1AlivaMab Discovery Services, San Diego, CA, USA

Shaden Omar

1AlivaMab Discovery Services, San Diego, CA, USA

Ritsuko Sawada

1AlivaMab Discovery Services, San Diego, CA, USA

Jonah Rainey

2Eli Lilly, Lilly Biotechnology Center, San Diego, CA, USA